The co-administration of the CTLA-4 antibody and human DC vaccines co-transfected with IDO siRNA, the tumor antigen survivin, and human telomerase reversed transcriptase (hTERT) enhanced anti-tumor immunity in a patient with metastatic melanoma [83]. Here, IDO1 is linked to neoplasm.